Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Borgny Ytterhus"'
Publikováno v:
PLoS ONE, Vol 18, Iss 6 (2023)
Introduction P21-activated kinase 1 (PAK1) is known to be overexpressed in several human tumour types, including breast cancer (BC). It is located on chromosome 11 (11q13.5-q14.1) and plays a significant role in proliferation in BC. In this study we
Externí odkaz:
https://doaj.org/article/54951c7d56474eb084828a73ac498737
Autor:
Sofie Eline Tollefsen, Anders H. Jarmund, Borgny Ytterhus, Øyvind Salvesen, Patricia Mjønes, Sverre Helge Torp
Publikováno v:
Cancers, Vol 13, Iss 22, p 5704 (2021)
Meningiomas have high recurrence rates despite frequently benign histopathological appearances. Somatostatin receptors (SSTRs) may be reliable biomarkers that could identify patients with increased risk of recurrence. Even though SSTRs are previously
Externí odkaz:
https://doaj.org/article/319f7d22fac544da8b862a156dc93024
Autor:
Magnus B. Arnli, Thomas Backer-Grøndahl, Borgny Ytterhus, Unn S. Granli, Stian Lydersen, Sasha Gulati, Sverre H. Torp
Publikováno v:
PeerJ, Vol 5, p e3140 (2017)
Background Meningiomas are common intracranial tumors in humans that frequently recur despite having a predominantly benign nature. Even though these tumors have been shown to commonly express EGFR/c-erbB1 (epidermal growth factor receptor), results
Externí odkaz:
https://doaj.org/article/2d0a488c186a43efa2cda6656ffe11e1
Publikováno v:
Bioingeniøren, Vol 44, Iss 2, Pp 6-10 (2009)
Spontaneous abortions or intrauterine foetal deaths are in 60-70 percent of the cases caused by trisomy 13, 18, 21 or Turner syndrome. Fluorescence in situ hybridization (FISH) with centromere or locus specific probes for chromosome 13, 18, 21, X and
Externí odkaz:
https://doaj.org/article/d968e099798a482c9e7da738690da8f4
Autor:
Signe Opdahl, Anna Mary Bofin, Borgny Ytterhus, Anne Irene Hagen, Johan Håkon Bjørngaard, Lars Andreas Akslen, Olav Anton Haugen, Monica Jernberg Engstrøm, Lars Johan Vatten, Marit Valla
Supplementary Table 3. Risk of death from breast cancer between diagnostic periods, for each molecular subtype 5 and 15 years after diagnosis (Cox regression analysis).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2096585946eb371af019aa273391ce0e
https://doi.org/10.1158/1055-9965.22437928
https://doi.org/10.1158/1055-9965.22437928
Autor:
Signe Opdahl, Anna Mary Bofin, Borgny Ytterhus, Anne Irene Hagen, Johan Håkon Bjørngaard, Lars Andreas Akslen, Olav Anton Haugen, Monica Jernberg Engstrøm, Lars Johan Vatten, Marit Valla
Supplementary Figure 2. Subtype-specific incidence rates according to age and year of birth. Blue lines: Women born before 1929. Red lines: Women born in 1929 or later. Dotted lines (red and blue) represent incidence rates of subtyped cases. Solid li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::177e23f78cf6f7016b3d986feee32432
https://doi.org/10.1158/1055-9965.22437943.v1
https://doi.org/10.1158/1055-9965.22437943.v1
Autor:
Signe Opdahl, Anna Mary Bofin, Borgny Ytterhus, Anne Irene Hagen, Johan Håkon Bjørngaard, Lars Andreas Akslen, Olav Anton Haugen, Monica Jernberg Engstrøm, Lars Johan Vatten, Marit Valla
Supplementary Figure 3. Cumulative incidence of death from breast cancer according to breast cancer subtypes. A: Women diagnosed before 1995 (Gray's test: p=0.0002). B: Women diagnosed in 1995 or later (Gray's test: p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e41ddb1f1a30169078f5438578501286
https://doi.org/10.1158/1055-9965.22437940
https://doi.org/10.1158/1055-9965.22437940
Autor:
Signe Opdahl, Anna Mary Bofin, Borgny Ytterhus, Anne Irene Hagen, Johan Håkon Bjørngaard, Lars Andreas Akslen, Olav Anton Haugen, Monica Jernberg Engstrøm, Lars Johan Vatten, Marit Valla
Supplementary Table 1. Characteristics of the study population used in estimations of breast cancer incidence.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13e40327a1810e607d91e22432416c08
https://doi.org/10.1158/1055-9965.22437934
https://doi.org/10.1158/1055-9965.22437934
Autor:
Signe Opdahl, Anna Mary Bofin, Borgny Ytterhus, Anne Irene Hagen, Johan Håkon Bjørngaard, Lars Andreas Akslen, Olav Anton Haugen, Monica Jernberg Engstrøm, Lars Johan Vatten, Marit Valla
Supplementary Table 2. Incidence rates and incidence rate ratios of breast cancer according to hormone and HER2 receptor status, age at diagnosis and year of birth. Observed and imputed estimates.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e9a7819ecd2eb10d829edfe0b076a03
https://doi.org/10.1158/1055-9965.22437931.v1
https://doi.org/10.1158/1055-9965.22437931.v1
Autor:
Signe Opdahl, Anna Mary Bofin, Borgny Ytterhus, Anne Irene Hagen, Johan Håkon Bjørngaard, Lars Andreas Akslen, Olav Anton Haugen, Monica Jernberg Engstrøm, Lars Johan Vatten, Marit Valla
Supplementary Table 5. Risk of death from breast cancer between diagnostic periods, for each breast cancer subtype 5 and 15 years after diagnosis (Cox regression analysis).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::674e892e2b683c74629077dcd0ad9484
https://doi.org/10.1158/1055-9965.22437925
https://doi.org/10.1158/1055-9965.22437925